NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

Completely agree Fireman; Les basically said the trap was set years ago, but I think many forgot. It should be clear to everyone now, why May 10th went down the way it did:

hyperopia
Re: Reefrad post# 475767
Post# 476210 of 546947 Go
Thursday, May 19, 2022 3:46:59 PM

Yeah right. Nothing to see here, move along.

Everyone (including Northwest Bio) knew that they would be attacked when the data was revealed. Northwest Bio could have waited to have the data presented in a journal when they would be permitted to PR this information and somewhat control the narrative, and yet they did not. Instead they chose to have the data presented at a prestigious scientific conference, while they were embargoed by a journal. (almost like walking around NY City with blinders on, holding their wallets out)

Northwest Bio could have disclosed what the new endpoints were in their 10-K in 2021, but did not. Instead they only disclosed that the endpoints were changed as required.

Northwest Bio could have updated the clinical trials registry at any time, but they did not. Instead they chose to make the request on the day of the presentation. (btw- what do you think would have happened to the share price if the clinical trial registry was updated days prior to the presentation?)

Hmmmm, and you say that they just happen to know the exact number of participants (15) that were involved in the “attack” that day?

Reefrad
RE: hyperopia post# 476210
Post# 476239 of 546946 Go
Thursday, 05/19/2022 04:36:14 PM

I have no idea what you are trying to get at with this post. I reported what I was told. My impression of Dave is that he is extremely genuine and when he can’t disclose something he tells me that. I don’t think he is dishonest. You guys can believe whatever you want including the secret BLA tote bag theory.

hyperopia
RE: Reefrad post# 476239
Post# 476324 of 546943 Go
Thursday, 05/19/2022 07:34:23 PM

Reefrad, I haven’t kept up with with board so I appreciate you sharing your conversation, and I apologize if I wasn’t very clear. I agree with your characterization of Dave as genuine and honest, and I think he is extremely knowledgable about the industry and markets, which is why I find it curious that he said that “the clinical trials update is a nothing burger and meaningless.“

I personally think that updating the clinical trials registry is a pretty big deal, and I believe it’s a prerequisite for the journal article, so I’m not sure why he is saying that it’s not related and is downplaying the significance. The timing of the update occurred when it did for a reason, and I don’t believe that it was just some afterthought to clear things up. Northwest Bio has been slow and deliberative in their actions and disclosures. So whether it’s for regulatory reasons, or they are gathering evidence for an investigation, or something else, I think there are likely valid reasons for the way things have played out this past week, but it appears Dave and Northwest Bio are not able to disclose this right now, and perhaps don’t want to draw attention to it.